Evidence map›Paper›PMID 32030418›Full record

ArticleMedical mycology2020

Clinical relevance of Scedosporium spp. and Exophiala dermatitidis in patients with cystic fibrosis: A nationwide study.

C C M de Jong, L Slabbers, T G P Engel, J B Yntema, M van Westreenen, P D Croughs, N Roeleveld, R Brimicombe, P E Verweij, J F Meis and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Medical mycology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.4field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Clinical and Molecular Advances on the Black YeastInternational journal of molecular sciences · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Dot Immunobinding Assay for the Rapid Serodetection ofJournal of fungi (Basel, Switzerland) · 2023
    Article
  12. Pathogenic Drug Resistant Fungi: A Review of Mitigation Strategies.International journal of molecular sciences · 2023
    Review
  13. The Presence ofJournal of fungi (Basel, Switzerland) · 2022
    Article
  14. Review
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

C C M de JongDepartment of Pediatrics, Radboud University Medical Center, Nijmegen, The Netherlands.
L SlabbersDepartment of Pediatrics, Radboud University Medical Center, Nijmegen, The Netherlands.
T G P EngelDepartment of Medical Micriobiology, Radboud University Medical Center, Nijmegen, The Netherlands.
J B YntemaDepartment of Pediatrics, Radboud University Medical Center, Nijmegen, The Netherlands.
M van WestreenenDepartment of Medical Microbiology and Infectious Diseases, Erasmus Medical Centre, Rotterdam, The Netherlands.
P D CroughsDepartment of Medical Microbiology and Infectious Diseases, Erasmus Medical Centre, Rotterdam, The Netherlands.
N RoeleveldDepartment for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
R BrimicombeDepartment of Medical Microbiology, HagaZiekenhuis, The Hague, The Netherlands.
P E VerweijDepartment of Medical Micriobiology, Radboud University Medical Center, Nijmegen, The Netherlands.
J F MeisDepartment of Medical Micriobiology, Radboud University Medical Center, Nijmegen, The Netherlands.
P J MerkusDepartment of Pediatrics, Radboud University Medical Center, Nijmegen, The Netherlands.
Radboud University Nijmegen · NLHaga Hospital · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An increased prevalence of various filamentous fungi in sputum samples of patients with cystic fibrosis (CF) has been reported. The clinical significance, however, is mostly unclear. The aim of this study was to investigate the clinical relevance of Scedosporium spp. and Exophiala dermatitidis from sputum samples of patients with CF in the Netherlands. In this cross-sectional study, all CF patients of the Dutch national CF registry who were treated at five of the seven recognized CF centers during a 3-year period were included. We linked clinical data of the national CF registry with the national Dutch filamentous fungal database. We investigated the association between clinical characteristics and a positive sputum sample for Scedosporium spp. and E. dermatitidis, using logistic regression. Positive cultures for fungi were obtained from 3787 sputum samples from 699 of the 1312 patients with CF. Scedosporium spp. was associated with severe genotype, CF-related diabetes, several microorganisms, and inhaled antibiotics. E. dermatitidis was associated with older age, female sex, and Aspergillus spp. CF patients with and without Scedosporium spp. or E. dermatitidis seemed comparable in body mass index and lung function. This study suggests that Scedosporium spp. and E. dermatitidis are probably no major pathogens in CF patients in the Netherlands. Greater understanding of epidemiologic trends, risk factors, and pathogenicity of filamentous fungi in the respiratory tracts of patients with CF is needed.

Indexed as

AdolescentAdultChildCross-Sectional StudiesCystic FibrosisExophialaFemaleHumansInvasive Fungal InfectionsMaleNetherlandsPhaeohyphomycosisPrevalenceScedosporiumSputumYoung Adultcystic fibrosisepidemiologyExophialafilamentous fungiScedosporium

Identifiers

PMID32030418
PMCPMC7527267
OpenAlexW3005403309

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.